Company intelligence / Profile preview

Justanned

Ownership: Private
Development stage: Commercial

Overview

Just - Evotec Biologics operates as a contract development and manufacturing organization (CDMO) with an innovative continuous biomanufacturing platform. It supports clients from discovery through commercial supply of biologic drugs. No proprietary clinical results are reported as they do not develop their own therapeutics pipeline but enable others' programs.

Modalities: Monoclonal antibodyRecombinant protein
Industry: Contract Manufacturing Organization

Partnerships

Sandoz (biosimilars development/manufacture agreement)Bristol Myers Squibb/Evotec partnership for neurodegenerative disease research

Beyond the preview

Go deeper on Justanned.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Justanned.

Explore the full profile